Patents by Inventor Dawei Ou

Dawei Ou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6180758
    Abstract: Synthetic peptides have an amino acids sequence corresponding to at least one antigenic determinant of at least one protein, usually a structural protein, particularly the E1, E2 or C proteins, of rubella virus (RV), are used as is, in hybrid or chimeric tandem T-B form, in lipidated form, linked to a carrier molecule and/or polymerized to form molecular aggregates, in vaccines against rubella. Analogs of peptides which are human T-cell determinants are used to treat rubella-associated autoimmune disorders.
    Type: Grant
    Filed: April 14, 1997
    Date of Patent: January 30, 2001
    Assignee: Connaught Laboratories Limited
    Inventors: Pele Chong, Shirley Gillam, Dawei Ou, Aubrey Tingle
  • Patent number: 6037448
    Abstract: Synthetic peptides have an amino acids sequence corresponding to at least one antigenic determinant of at least one protein, usually a structural protein, particularly the E1, E2 or C proteins, of rubella virus (RV), are used as is, in hybrid or chimeric tandem T-B form, in lipidated form, linked to a carrier molecule and/or polymerized to form molecular aggregates, in vaccines against rubella. Analogs of peptides which are human T-cell determinants are used to treat rubella-associated autoimmune disorders.
    Type: Grant
    Filed: October 6, 1994
    Date of Patent: March 14, 2000
    Assignee: Connaught Laboratories Limited
    Inventors: Pele Chong, Shirley Gillam, Dawei Ou, Aubrey Tingle